Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells

Anticancer Res. 2010 Mar;30(3):945-51.

Abstract

In our primary studies, we have shown that emodin, aloe-emodin and rhein induced cytotoxic effects, including cell cycle arrest and apoptosis in SCC-4 human tongue cancer cells. However, details regarding their effects on DNA damage and repair gene expression in SCC-4 cells are not clear. We investigated whether or not emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 cells. Comet assay (single cell electrophoresis) indicated that incubation of SCC-4 cells with 0, 20, 30 and 40 microM of emodin, 0, 25, 50 and 100 microM of aloe-emodin or rhein led to a longer DNA migration smear (comet tail). This means that all examined agents induced DNA damage in SCC-4 cells and these effects are dose-dependent but emodin is stronger than that of aloe-emodin or rhein. The results from real-time PCR assay demonstrated that 30 microM of emodin or aloe-emodin used for 24 and 48 h treatment in SCC-4 cells significantly inhibited expression of genes associated with DNA damage and repair [ataxia telangiectasia mutated (ATM); ataxia-telangiectasia and Rad3-related (ATR); 14-3-3sigma (14-3-3sigma); breast cancer 1, early onset (BRCA1); and DNA-dependent serine/threonine protein kinase (DNA-PK)]; only rhein suppressed the expression of O(6)-methylguanine-DNA methyltransferase (MGMT) mRNA with 48 h treatment, but had no effect on ATM expression. On 24 h treatment, only aloe-emodin significantly affected ATM expression. These effects may be the vital factors for emodin, aloe-emodin and rhein induction of DNA damage in vitro. In conclusion, these agents induced DNA damage followed by the inhibition of DNA repair-associated gene expressions, including ATM, ATR, 14-3-3sigma, BRCA1, DNA-PK and MGMT in SCC-4 human tongue cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins
  • Anthraquinones / pharmacology*
  • Ataxia Telangiectasia Mutated Proteins
  • BRCA1 Protein / biosynthesis
  • BRCA1 Protein / genetics
  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / genetics
  • Cell Cycle Proteins / biosynthesis
  • Cell Cycle Proteins / genetics
  • Cell Line, Tumor
  • Comet Assay
  • DNA Damage
  • DNA Modification Methylases / biosynthesis
  • DNA Modification Methylases / genetics
  • DNA Repair / drug effects
  • DNA Repair / genetics
  • DNA Repair Enzymes / antagonists & inhibitors*
  • DNA Repair Enzymes / biosynthesis
  • DNA Repair Enzymes / genetics
  • DNA-Activated Protein Kinase / biosynthesis
  • DNA-Activated Protein Kinase / genetics
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • Emodin / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Exonucleases / biosynthesis
  • Exonucleases / genetics
  • Exoribonucleases
  • Gene Expression / drug effects
  • Humans
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Polymerase Chain Reaction
  • Protein Serine-Threonine Kinases / biosynthesis
  • Protein Serine-Threonine Kinases / genetics
  • Tongue Neoplasms / drug therapy*
  • Tongue Neoplasms / genetics*
  • Tongue Neoplasms / metabolism
  • Tumor Suppressor Proteins / antagonists & inhibitors*
  • Tumor Suppressor Proteins / biosynthesis
  • Tumor Suppressor Proteins / genetics

Substances

  • 14-3-3 Proteins
  • Anthraquinones
  • BRCA1 Protein
  • Biomarkers, Tumor
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • Tumor Suppressor Proteins
  • aloe emodin
  • DNA Modification Methylases
  • MGMT protein, human
  • ATM protein, human
  • ATR protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • DNA-Activated Protein Kinase
  • Protein Serine-Threonine Kinases
  • Exonucleases
  • Exoribonucleases
  • SFN protein, human
  • DNA Repair Enzymes
  • Emodin
  • rhein